"10.1371_journal.pone.0149108","plos one","2016-02-12T00:00:00Z","Leonardo Potenza; Daniela Vallerini; Patrizia Barozzi; Giovanni Riva; Andrea Gilioli; Fabio Forghieri; Anna Candoni; Simone Cesaro; Chiara Quadrelli; Johan Maertens; Giulio Rossi; Monica Morselli; Mauro Codeluppi; Cristina Mussini; Elisabetta Colaci; Andrea Messerotti; Ambra Paolini; Monica Maccaferri; Valeria Fantuzzi; Cinzia Del Giovane; Alessandro Stefani; Uliano Morandi; Rossana Maffei; Roberto Marasca; Franco Narni; Renato Fanin; Patrizia Comoli; Luigina Romani; Anne Beauvais; Pier Luigi Viale; Jean Paul Latgè; Russell E Lewis; Mario Luppi","Section of Hematology, Department of Surgical and Medical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy; Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia di Udine, Udine, Italy; Pediatric Hematology/Oncology, Policlinico GB Rossi, Verona, Italy; Department of Hematology, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Leuven, Belgium; Department of Pathology, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy; Clinic of Infectious Diseases, Integrated Department of Medicine, Emergency Medicine and Medical Specialties, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy; Section of Statistics, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy; Division of Thoracic Surgery, Department of Surgical and Medical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy; Pediatric Hematology/Oncology and Transplantation, IRCCS Policlinico S. Matteo, Pavia, Italy; Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy; Unitè des Aspergillus, Pasteur Institut, Paris, France; Clinic of Infectious Diseases, Department of Internal Medicine, Geriatrics and Nephrologic Diseases, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy","Conceived and designed the experiments: LP ML. Performed the experiments: DV PB G. Riva CQ. Analyzed the data: AG. Contributed reagents/materials/analysis tools: G. Rossi AP R. Maffei VF CDG AB JPL. Wrote the paper: LP ML AG. Enrolled patients: FF AC SC JM M. Morselli MC CM EC AM M. Maccaferri AS UM R. Marasca FN RF. Interpreted data: PC LR. Interpreted data and critically revised the manuscript: PLV REL.","Mario Luppi received research funds from and served on the advisory board for Gilead Sciences, Merck Sharp and Dome, and Pfizer; Leonardo Potenza received research funds and honoraria from Gilead Sciences, Merck Sharp and Dohme, and Pfizer. LP, PB, and ML have applied for a European and US patent regarding clinical applications of the ELISpot assay for the diagnosis of Aspergillus infection [PCT: WO2008/075395A3, EP2094295, IT2007/000867]. LP, DV, PB, FF, and ML have applied for an Italian patent regarding clinical applications of the ELISpot assay for the diagnosis of Mucorales infection (No. MI2010A002224). These do not alter the adherence of authors to all PLOS ONE policies on sharing data and materials. All the other authors have no pertinent commercial relationships related to the manuscript. LP, DV, PB, FF, and ML have applied for an Italian patent regarding clinical applications of the ELISpot assay for the diagnosis of Mucorales infection (No. MI2010A002224). All the other authors have declared that no competing interests exist.","2016","02","Leonardo Potenza","LP",33,FALSE,2,3,1,3,TRUE,FALSE,TRUE,9,"9;15;17;19;21;25;26;29;31",TRUE
